These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23261783)

  • 1. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.
    Ma Y; Halade GV; Zhang J; Ramirez TA; Levin D; Voorhees A; Jin YF; Han HC; Manicone AM; Lindsey ML
    Circ Res; 2013 Feb; 112(4):675-88. PubMed ID: 23261783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution.
    Iyer RP; Patterson NL; Zouein FA; Ma Y; Dive V; de Castro Brás LE; Lindsey ML
    Int J Cardiol; 2015 Apr; 185():198-208. PubMed ID: 25797678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building a better infarct: Modulation of collagen cross-linking to increase infarct stiffness and reduce left ventricular dilation post-myocardial infarction.
    Voorhees AP; DeLeon-Pennell KY; Ma Y; Halade GV; Yabluchanskiy A; Iyer RP; Flynn E; Cates CA; Lindsey ML; Han HC
    J Mol Cell Cardiol; 2015 Aug; 85():229-39. PubMed ID: 26080361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.
    Noppe G; Dufeys C; Buchlin P; Marquet N; Castanares-Zapatero D; Balteau M; Hermida N; Bouzin C; Esfahani H; Viollet B; Bertrand L; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S
    J Mol Cell Cardiol; 2014 Sep; 74():32-43. PubMed ID: 24805196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.
    Meschiari CA; Jung M; Iyer RP; Yabluchanskiy A; Toba H; Garrett MR; Lindsey ML
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H224-H235. PubMed ID: 29030341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P. gingivalis lipopolysaccharide intensifies inflammation post-myocardial infarction through matrix metalloproteinase-9.
    DeLeon-Pennell KY; de Castro Brás LE; Iyer RP; Bratton DR; Jin YF; Ripplinger CM; Lindsey ML
    J Mol Cell Cardiol; 2014 Nov; 76():218-26. PubMed ID: 25240641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair.
    Nawaito SA; Sahadevan P; Clavet-Lanthier MÉ; Pouliot P; Sahmi F; Shi Y; Gillis MA; Lesage F; Gaestel M; Sirois MG; Calderone A; Tardif JC; Allen BG
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1281-H1296. PubMed ID: 30901279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
    Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
    J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related differences in postinfarct left ventricular rupture and remodeling.
    Yang Y; Ma Y; Han W; Li J; Xiang Y; Liu F; Ma X; Zhang J; Fu Z; Su YD; Du XJ; Gao XM
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1815-22. PubMed ID: 18263717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction.
    Sun M; Dawood F; Wen WH; Chen M; Dixon I; Kirshenbaum LA; Liu PP
    Circulation; 2004 Nov; 110(20):3221-8. PubMed ID: 15533863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilysin (matrix metalloproteinase-28) joins the matrix metalloproteinase team on the field of postmyocardial infarction remodeling.
    Spinale FG
    Circ Res; 2013 Feb; 112(4):579-82. PubMed ID: 23410875
    [No Abstract]   [Full Text] [Related]  

  • 12. Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction.
    Zamilpa R; Ibarra J; de Castro Brás LE; Ramirez TA; Nguyen N; Halade GV; Zhang J; Dai Q; Dayah T; Chiao YA; Lowell W; Ahuja SS; D'Armiento J; Jin YF; Lindsey ML
    J Mol Cell Cardiol; 2012 Nov; 53(5):599-608. PubMed ID: 22884843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-35 Promotes Macrophage Survival and Improves Wound Healing After Myocardial Infarction in Mice.
    Jia D; Jiang H; Weng X; Wu J; Bai P; Yang W; Wang Z; Hu K; Sun A; Ge J
    Circ Res; 2019 Apr; 124(9):1323-1336. PubMed ID: 30832557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
    Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
    Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC mediates early extracellular matrix remodeling following myocardial infarction.
    McCurdy SM; Dai Q; Zhang J; Zamilpa R; Ramirez TA; Dayah T; Nguyen N; Jin YF; Bradshaw AD; Lindsey ML
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H497-505. PubMed ID: 21602472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
    Tsujita K; Kaikita K; Hayasaki T; Honda T; Kobayashi H; Sakashita N; Suzuki H; Kodama T; Ogawa H; Takeya M
    Circulation; 2007 Apr; 115(14):1904-11. PubMed ID: 17389263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Ikeuchi M; Shiomi T; Matsusaka H; Kubota T; Imanaka-Yoshida K; Itoh T; Takeshita A
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1229-35. PubMed ID: 12775562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.
    Kain V; Ingle KA; Kabarowski J; Barnes S; Limdi NA; Prabhu SD; Halade GV
    J Mol Cell Cardiol; 2018 May; 118():70-80. PubMed ID: 29526491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM15 is required for optimal collagen cross-linking and scar formation following myocardial infarction.
    Chute M; Aujla PK; Li Y; Jana S; Zhabyeyev P; Rasmuson J; Owen CA; Abraham T; Oudit GY; Kassiri Z
    Matrix Biol; 2022 Jan; 105():127-143. PubMed ID: 34995785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.